Document is current
Any future updates will be listed below
-
Authors
Liu, Yunxia
Chen, Ruoyu
Gao, Xiaoyue
Zhu, Fen
Ni, Qinyu https://orcid.org/0009-0004-3220-1955
Bates, Paul D.
Wu, Sunny
Zai, Zhuoyan
Obernberger, Victoria A.
Weerawardhene, Kavinu
Tourdot, Taylor K.
Petta, Sophie
Conyers, Madison J.
Capitini, Christian M. https://orcid.org/0000-0002-2276-6731
Rui, Lixin https://orcid.org/0000-0002-5762-8937
- License Information
-
More Information
Article History
Received: 6 January 2026
Revised: 9 February 2026
Accepted: 10 March 2026
First Online: 17 April 2026
Competing interests
: C.M.C. received honorarium from Bayer and Novartis, and has equity interest in Elephas, for advisory board memberships. These companies had no input in the study design, analysis, manuscript preparation or decision to submit for publication. All other authors declare they have no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Primary human MCL samples were obtained as de‑identified specimens with informed consent and under IRB‑approved protocols. Animal experiments in this study were approved by the Animal Care and Use Committee (IACUC) of the University of Wisconsin–Madison (protocol M005915). De‑identified human samples were expanded in NSG mice before use.
